Zang, Xiao and Skinner, Alexandra and Krieger, Maxwell S and Behrends, Czarina N and Park, Ju N and Green, Traci C and Walley, Alexander Y and Morgan, Jake R and Linas, Benjamin P and Yedinak, Jesse L and Schackman, Bruce R and Marshall, Brandon D L (2024) Evaluation of strategies to enhance community-based naloxone distribution supported by an opioid settlement. JAMA Network Open, 7, (5), e2413861. https://doi.org/10.1001/jamanetworkopen.2024.13861.
External website: https://jamanetwork.com/journals/jamanetworkopen/f...
IMPORTANCE Many US states are substantially increasing community-based naloxone distribution, supported in part through settlements from opioid manufacturers and distributors.
OBJECTIVES To evaluate the potential impact of increased naloxone availability on opioid overdose deaths (OODs) and explore strategies to enhance this impact by integrating interventions to address solitary drug use.
DESIGN, SETTING, AND PARTICIPANTS This decision analytical modeling study used PROFOUND (Prevention and Rescue of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies), a previously published simulation model, to forecast annual OODs between January 2023 and December 2025. The simulated study population included individuals from Rhode Island who misused opioids and stimulants and were at risk for opioid overdose.
EXPOSURES The study modeled expanded naloxone distribution supported by the state's opioid settlement (50 000 naloxone nasal spray kits each year). Two approaches to expanding naloxone distribution were evaluated: one based on historical spatial patterns of naloxone distribution (supply-based approach) and one based on the spatial distribution of individuals at risk (demand-based approach). In addition, hypothetical interventions to enhance the likelihood of witnessed overdoses in private or semiprivate settings were considered.
MAIN OUTCOMES AND MEASURES Annual number of OODs and ratio of fatal to nonfatal opioid overdoses.
RESULTS Modeling results indicated that distributing more naloxone supported by the state's opioid settlement could reduce OODs by 6.3% (95% simulation interval [SI], 0.3%-13.7%) and 8.8% (95% SI, 1.8%-17.5%) in 2025 with the supply-based and demand-based approaches, respectively. However, increasing witnessed overdoses by 20% to 60% demonstrated greater potential for reducing OODs, ranging from 8.5% (95% SI, 0.0%-20.3%) to 24.1% (95% SI, 8.6%-39.3%). Notably, synergistic associations were observed when combining both interventions: increased naloxone distribution with the 2 approaches and a 60% increase in witnessed overdoses could reduce OODs in 2025 by 33.5% (95% SI, 17.1%-50.4%) and 37.4% (95% SI, 19.6%-56.3%), respectively.
CONCLUSIONS AND RELEVANCE These findings suggest that interventions to address solitary drug use are needed to maximize the impact of continued efforts to increase community-based naloxone distribution, which may be particularly important for jurisdictions that have strong community-based naloxone distribution programs.
B Substances > Opioids (opiates) > Opioid product > Naloxone
B Substances > New (novel) psychoactive substances > Synthetic opioids > Fentanyl, Fentanils
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug intoxication > Poisoning (overdose)
MP-MR Policy, planning, economics, work and social services > Programme planning, implementation, and evaluation > Programme evaluation
VA Geographic area > United States
Repository Staff Only: item control page